Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma: Updates From a French Prospective Multicenter Study.

Published on Nov 1, 2017in Annals of Surgery10.13
· DOI :10.1097/SLA.0000000000002432
Jean Robert Delpero30
Estimated H-index: 30
Florence Jeune1
Estimated H-index: 1
+ 10 AuthorsJean Marie Boher11
Estimated H-index: 11
Objective:The aim of the study was to assess the relevance of resection margin status for survival after resection of pancreatic-head ductal adenocarcinoma.Summary Background Data:The definition and prognostic value of incomplete microscopic resection (R1) remain controversial.Methods:Prognostic fac
📖 Papers frequently viewed together
13 Authors (Helmut Oettle, ..., Hanno Riess)
954 Citations
751 Citations
487 Citations
#1Giovanni Marchegiani (Harvard University)H-Index: 29
#2Stefano AndrianelloH-Index: 16
Last. Roberto SalviaH-Index: 23
view all 12 authors...
To explore the role of pancreatic ductal adenocarcinoma (PDAC) size on surgical and survival outcomes.Tumor size is a prognostic factor for the majority of solid cancers, but the role for PDAC in predicting survival is not well delineated affecting the reliability of tumor node metastasis system classification.Between 1998 and 2012, 1507 patients with PDAC underwent resection at University of Verona Hospital and the Massachusetts General Hospital. All data were collected prospectively. Tumor siz...
54 CitationsSource
#1John P. Neoptolemos (University of Liverpool)H-Index: 125
#2Daniel H. Palmer (University of Liverpool)H-Index: 44
Last. Markus W. Büchler (Heidelberg University)H-Index: 91
view all 34 authors...
Summary Background The ESPAC-3 trial showed that adjuvant gemcitabine is the standard of care based on similar survival to and less toxicity than adjuvant 5-fluorouracil/folinic acid in patients with resected pancreatic cancer. Other clinical trials have shown better survival and tumour response with gemcitabine and capecitabine than with gemcitabine alone in advanced or metastatic pancreatic cancer. We aimed to determine the efficacy and safety of gemcitabine and capecitabine compared with gemc...
835 CitationsSource
#1Peter J. Allen (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 97
#2Deborah KukH-Index: 36
Last. Mari Mino-KenudsonH-Index: 93
view all 15 authors...
Objective:The aim of this study was to evaluate and validate the proposed 8th edition American Joint Committee on Cancer (AJCC) system for T and N staging of pancreatic adenocarcinoma.Summary of Background Data:Investigators have questioned the clinical relevance and reproducibility of previous AJCC
218 CitationsSource
#1Hryhoriy Lapshyn (University Medical Center Freiburg)H-Index: 9
#2Louisa BolmH-Index: 10
Last. Ulrich F. WellnerH-Index: 30
view all 12 authors...
Abstract Background Mesenterico-portal vein resection (PVR) during pancreatoduodenectomy for pancreatic head cancer was established in the 1990s and can be considered a routine procedure in specialized centers today. True histopathologic portal vein invasion is predictive of poor prognosis. The aim of this study was to examine the relationship between mesenterico-portal venous tumor infiltration (PVI) and features of aggressive tumor biology. Methods Patients receiving PVR for pancreatic ductal ...
11 CitationsSource
#1James R. Butler (IU: Indiana University)H-Index: 14
#2Syed A. Ahmad (UC: University of Cincinnati)H-Index: 54
Last. Nicholas J. Zyromski (IU: Indiana University)H-Index: 35
view all 5 authors...
Background Resectable pancreatic ductal adenocarcinoma continues to carry a poor prognosis. Of the controllable clinical variables known to affect outcome, margin status is paramount. Though the importance of a R0 resection is generally accepted, not all margins are easily managed. The superior mesenteric artery [SMA] in particular is the most challenging to clear. The aim of this study was to systematically review the literature with specific focus on the role of a SMA periadventitial dissectio...
30 CitationsSource
#1Manju D. Chandrasegaram (University of Adelaide)H-Index: 11
#2David Goldstein (UNSW: University of New South Wales)H-Index: 157
Last. Andrew Barbour (Princess Alexandra Hospital)H-Index: 58
view all 10 authors...
Background R0 resection rates (complete tumour removal with negative resection margins) in pancreatic cancer are 70–80 per cent when a 0-mm margin is used, declining to 15–24 per cent with a 1-mm margin. This review evaluated the R0 resection rates according to different margin definitions and techniques. Methods Three databases (MEDLINE from 1946, PubMed from 1946 and Embase from 1949) were searched to mid-October 2014. The search terms included ‘pancreatectomy OR pancreaticoduodenectomy’ and ‘...
106 CitationsSource
#1Li Liu (University of Texas MD Anderson Cancer Center)H-Index: 3
#2Matthew H.G. KatzH-Index: 66
Last. Huamin Wang (University of Texas MD Anderson Cancer Center)H-Index: 82
view all 16 authors...
: Negative-margin resection is crucial to favorable prognosis in patients with pancreatic ductal adenocarcinoma. However, the definition of a negative superior mesenteric artery margin (SMAM) varies. The College of American Pathologists defines positive SMAM as the presence of tumor cells at the margin, whereas the European protocol is based on a 1 mm clearance. In this study, we examined the prognostic significance of the SMAM distance in 411 consecutive pancreatic ductal adenocarcinoma patient...
35 CitationsSource
#1Oliver Strobel (University Hospital Heidelberg)H-Index: 50
#2Ulf HinzH-Index: 64
Last. Markus W. BüchlerH-Index: 173
view all 8 authors...
Abstract To determine the prognostic value of PLN and LNR based on a large series with standardized lymphadenectomy and pathological workup. Lymph node (LN) involvement is a major prognostic factor in pancreatic adenocarcinoma. However, the distinction N0/N1 is not sufficient to accurately predict prognosis. To improve prognostic accuracy in N1 tumors, different LN parameters have been tested. Previous studies were based on series with variable numbers of examined lymph nodes (ELN) and came to i...
123 CitationsSource
Last. D. J. GoumaH-Index: 68
view all 7 authors...
BACKGROUND: According to some studies, the number of lymph nodes with metastases in relation to the total number of removed lymph nodes, the lymph node ratio (LNR), is one of the most powerful predictors of survival after resection in patients with pancreatic cancer. However, contradictory results have been reported, and small sample sizes of the cohorts and different definitions of a microscopic positive resection margin (R1) hamper the interpretation of data. METHODS: The predictive value of L...
73 CitationsSource
#1Florian Gebauer (UHH: University of Hamburg)H-Index: 20
#2Michael Tachezy (UHH: University of Hamburg)H-Index: 22
Last. Maximilian Bockhorn (UHH: University of Hamburg)H-Index: 25
view all 7 authors...
Background and objectives The aim of this study was to assess the overall survival (OS) after R0/R1 resections in patients with pancreatic ductal adenocarcinoma (PDAC) of the pancreatic head after implementation of a standardized histopathologic protocol (Leeds Pathology Protocol, LEEPP).
49 CitationsSource
Cited By48
The mesopancreas does not have well-defined boundaries but is continuous and connected through its components with the paraaortic area. The mesopancreatic resection margin has been indicated as the primary site for R1 resection after PD in pancreatic head cancer and total mesopancreas excision has been proposed to achieve adequate retropancreatic margin clearance and to minimize the likelihood of R1 resection. However, the anatomy of the mesopancreas requires extended dissection of the paraaorti...
#1Jonathan GarnierH-Index: 6
#2Jacques EwaldH-Index: 11
Last. Olivier Turrini (AMU: Aix-Marseille University)H-Index: 37
view all 8 authors...
Purpose: Using a standardized specimen protocol analysis, this study aimed to evaluate the resection margin status of patients who underwent resection for either distal cholangiocarcinoma (DC) or pancreatic ductal adenocarcinoma (PDAC). This allowed a precise millimetric analysis of each inked margin. Methods: From 2010 to 2018, 355 consecutively inked specimens from patients with PDAC (n = 288) or DC (n = 67) were prospectively assessed. We assessed relationships between the tumor and the follo...
#1Yuichi Nagakawa (TMU: Tokyo Medical University)H-Index: 23
#2Naoya Nakagawa (TMU: Tokyo Medical University)H-Index: 1
Last. Tomoki Shirota (TMU: Tokyo Medical University)H-Index: 4
view all 14 authors...
Patients with resectable pancreatic cancer are considered to already have micro-distant metastasis, because most of the recurrence patterns postoperatively are distant metastases. Multimodal treatment dramatically improves prognosis; thus, micro-distant metastasis is considered to be controlled by chemotherapy. The survival benefit of “regional lymph node dissection” for pancreatic head cancer remains unclear. We reviewed the literature that could be helpful in determining the appropriate resect...
1 CitationsSource
#1Eduardo de Souza M. Fernandes (DaimlerChrysler Aerospace)H-Index: 1
#1Eduardo Fernandes (DaimlerChrysler Aerospace)H-Index: 16
Last. Orlando Jorge M Torres (DaimlerChrysler Aerospace)H-Index: 1
view all 5 authors...
BACKGROUND Pancreatoduodenectomy is the only treatment with a promise of cure for patients with pancreatic head adenocarcinoma, and a negative resection margin is an important factor related to overall survival. Complete clearance of the medial margin with removal of the so-called mesopancreas may decrease the recurrence rate after pancreatic resection. Here, we present some important information about the mesopancreas, total mesopancreas excision, and technical aspects to achieve negative resec...
1 CitationsSource
#1Benno Traub (University of Ulm)H-Index: 3
#2K. H. Link (University of Ulm)H-Index: 11
Last. Marko Kornmann (University of Ulm)H-Index: 37
view all 3 authors...
The distinct biology of pancreatic cancer with aggressive and early invasive tumor cells, a tumor promoting microenvironment, late diagnosis, and high therapy resistance poses major challenges on clinicians, researchers, and patients. In current clinical practice, a curative approach for pancreatic cancer can only be offered to a minority of patients and even for those patients, the long-term outcome is grim. This bitter combination will eventually let pancreatic cancer rise to the second leadin...
#1Gennaro NappoH-Index: 7
#2Domenico Borzomati (Università Campus Bio-Medico)H-Index: 19
Last. Damiano Caputo (Università Campus Bio-Medico)H-Index: 14
view all 16 authors...
Background There is extreme heterogeneity in the available literature on the determination of R1 resection rate after pancreatoduodenectomy (PD); consequently, its prognostic role is still debated. The aims of this multicenter randomized study were to evaluate the effect of sampling and clearance definition in determining R1 rate after PD for periampullary cancer and to assess the prognostic role of R1 resection. Methods PD specimens were randomized to Leeds Pathology Protocol (LEEPP) (group A) ...
#1Jonathan GarnierH-Index: 6
#2Eddy TraversariH-Index: 1
Last. Olivier Turrini (AMU: Aix-Marseille University)H-Index: 37
view all 6 authors...
BACKGROUND Although primary end-to-end anastomosis is preferred for portal vein-superior mesenteric vein (PV-SMV) reconstruction, interposition graft use may be required in some situations. We investigated the efficacy of polytetrafluoroethylene (PTFE) grafts when used during pancreatectomy in this context. METHODS From 2014 to 2019, 19 patients who underwent pancreatectomy requiring PV-SMV reconstruction using ringed PTFE grafts were entered prospectively into a clinical database (NCT02871336, ...
1 CitationsSource
#1Gaëtan-Romain Joliat (UNIL: University of Lausanne)H-Index: 12
#2Pierre Allemann (UNIL: University of Lausanne)H-Index: 20
Last. Markus Schäfer (UNIL: University of Lausanne)H-Index: 40
view all 13 authors...
Abstract Background Resection margin status and lymph node (LN) involvement are known prognostic factors for patients who undergo pancreatoduodenectomy for pancreatic ductal adenocarcinoma (PDAC). This study aimed to compare overall survival (OS) and disease-free survival (DFS) by resection margin status in patients with PDAC and LN involvement. Methods A retrospective international multicentric study was performed including four Western centers. Multivariable Cox analysis was performed to ident...
#1Richard Zheng (Thomas Jefferson University)H-Index: 4
#2David Nauheim (Thomas Jefferson University)H-Index: 2
Last. Adam C. Berger (RU: Rutgers University)H-Index: 50
view all 10 authors...
The impact of resecting positive margins during pancreaticoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDA) remains debated. Additionally, the survival benefit of resecting multiple positive margins is unknown. We identified patients with PDA who underwent PD from 2006 to 2015. Pancreatic neck, bile duct, and uncinate frozen section margins were assessed before and after resection of positive margins. Survival curves were compared with log-rank tests. Multivariable Cox regression ass...
3 CitationsSource
#1Julie Navez (ULB: Université libre de Bruxelles)H-Index: 2
#2Christelle Bouchart (Institut Jules Bordet)H-Index: 3
Last. Jean-Luc Van Laethem (ULB: Université libre de Bruxelles)H-Index: 56
view all 6 authors...
Complete surgical resection, most often associated with perioperative chemotherapy, is the only way to offer a chance of cure for patients with pancreatic cancer. One of the most important factors in determining survival outcome that can be influenced by the surgeon is the R0 resection. However, the proximity of mesenteric vessels in cephalic pancreatic tumors, especially the mesenterico-portal venous axis, results in an increased risk of vein involvement and/or the presence of malignant cells i...